Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Publication year range
1.
Virulence ; 12(1): 35-44, 2021 12.
Article in English | MEDLINE | ID: mdl-33372844

ABSTRACT

Convergence of virulence and antibiotic-resistance has been reported in Klebsiella pneumoniae, but not in Klebsiella variicola. We, hereby, report the detection and genomic characterization of hypervirulent and hypermucoviscous K. pneumoniae and K.variicola recovered in Chile from health-care associated infections, which displayed resistance to broad-spectrum cephalosporins. One hundred forty-six K. pneumoniae complex isolates were screened by hypermucoviscosity by the "string test." Two hypermucoid isolates, one hypermucoviscous K. pneumoniae (hmKp) and one K. variicola (hmKv), were further investigated by whole-genome sequencing. In vivo virulence was analyzed by the Galleria mellonella killing assay. In silico analysis of hmKp UCO-494 and hmKv UCO-495 revealed the presence of multiple antibiotic-resistance genes, such as blaCTX-M-1, blaDHA-1 and blaLEN-25 among others clinically relevant resistance determinants, including mutations in a two-component regulatory system related to colistin resistance. These genetic features confer a multidrug-resistant (MDR) phenotype in both strains. Moreover, virulome in silico analysis confirmed the presence of the aerobactin gene iutA, in addition to yersiniabactin and/or colicin V encoding genes, which are normally associated to high virulence in humans. Furthermore, both isolates were able to kill G. mellonella and displayed higher virulence in comparison with the control strain. In summary, the convergence of virulence and the MDR-phenotype in K. pneumoniae complex members is reported for the first time in Chile, denoting a clinical problem that deserves special attention and continuous surveillance in South America.


Subject(s)
Drug Resistance, Multiple, Bacterial/genetics , Klebsiella pneumoniae/genetics , Klebsiella pneumoniae/pathogenicity , Klebsiella/genetics , Klebsiella/pathogenicity , Animals , Anti-Bacterial Agents/pharmacology , Biofilms/growth & development , Chile , Genome, Bacterial/genetics , Humans , Klebsiella/enzymology , Klebsiella Infections/microbiology , Klebsiella pneumoniae/enzymology , Larva/microbiology , Microbial Sensitivity Tests , Moths/microbiology , Virulence Factors/genetics , Whole Genome Sequencing
2.
Int J Tuberc Lung Dis ; 15(4): 542-6, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21396216

ABSTRACT

BACKGROUND: Community-acquired pneumonia (CAP) severity scores can identify patients at low risk for mortality who may be suitable for ambulatory care. Here, we follow the clinical course of hospitalized patients with CAP due to 2009 H1N1 influenza. OBJECTIVE: To evaluate the role of CAP severity scores as predictors of mortality. METHODS: This was a secondary data analysis of patients hospitalized with CAP due to 2009 H1N1 influenza confirmed by reverse transcriptase polymerase chain reaction enrolled in the CAPO (Community-Acquired Pneumonia Organization) international cohort study. CAP severity scores PSI (Pneumonia Severity Index), CURB-65 (confusion, urea, respiratory rate, blood pressure, age ≥ 65 years) and CRB-65 (confusion, respiratory rate, blood pressure, age ≥ 65 years) were calculated. Actual and predicted mortality rates were compared. A total of 37 predictor variables were evaluated to define those associated with mortality. RESULTS: Data from 250 patients with CAP due to 2009 H1N1 influenza were analyzed. Patients with low predicted mortality rates (0-1.5%) had actual mortality rates ranging from 2.6% to 17.5%. Obesity and wheezing were the only novel variables associated with mortality. CONCLUSIONS: The decision to hospitalize a patient with CAP due to 2009 H1N1 influenza should not be based on current CAP severity scores, as they underestimate mortality rates in a significant number of patients. Patients with obesity or wheezing should be considered at an increased risk for mortality.


Subject(s)
Community-Acquired Infections/mortality , Influenza A Virus, H1N1 Subtype/isolation & purification , Influenza, Human/mortality , Pneumonia, Viral/mortality , Adult , Aged , Cohort Studies , Community-Acquired Infections/physiopathology , Community-Acquired Infections/virology , Female , Forecasting , Hospitalization , Humans , Influenza, Human/complications , Influenza, Human/physiopathology , Male , Middle Aged , Obesity/complications , Pneumonia, Viral/physiopathology , Pneumonia, Viral/virology , Respiratory Sounds/physiopathology , Risk Factors , Severity of Illness Index
3.
Eur Respir J ; 36(4): 864-9, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20185421

ABSTRACT

As the pandemic of 2009 H1N1 influenza A virus progressed, more patients required hospitalisation. The objective of this study is to describe the characteristics and clinical course of hospitalised patients with 2009 H1N1 virus infection in Chile. This was a prospective, observational study of 100 consecutive hospitalised patients with RT-PCR-confirmed 2009 H1N1 influenza A, admitted to Puerto Montt General Hospital (Puerto Montt, Chile). Information was obtained regarding contact history, demographics, laboratory values and clinical course. The primary reason for hospitalisation was pneumonia, in 75% of patients. Rapid influenza A test was positive in 51% of patients. Prior exposure to 2009 H1N1 virus was documented in 21% of patients. Clinical failure, documented in 18% of cases, was characterised by respiratory failure and acute respiratory distress syndrome. Failure was more common in patients with obesity, tachypnoea, confusion and multilobar infiltrates. When evaluating a patient hospitalised with influenza-like illness, a negative rapid test for influenza A or negative contact with a suspected case should not alter physicians' considerations regarding the likelihood of 2009 H1N1 virus infection. Patients with 2009 H1N1 virus infection with obesity, tachypnoea, confusion and multilobar infiltrates should be closely monitored since they are at high risk for clinical failure.


Subject(s)
Influenza A Virus, H1N1 Subtype/metabolism , Influenza, Human/epidemiology , Influenza, Human/virology , Adult , Anti-Bacterial Agents/pharmacology , Antiviral Agents/pharmacology , Chile , Female , Humans , Influenza, Human/complications , Male , Middle Aged , Obesity/complications , Pandemics , Prospective Studies , Reverse Transcriptase Polymerase Chain Reaction , Risk , Time Factors , Treatment Outcome
4.
Rev Med Chil ; 124(6): 715-9, 1996 Jun.
Article in Spanish | MEDLINE | ID: mdl-9041729

ABSTRACT

BACKGROUND: The frequency of Streptococcus pyogenes infections with deep tissue invasion and toxic shock syndrome has increased in the last decade throughout the world. AIM: To compare antimicrobial susceptibility of S. pyogenes strains isolated during 1986 and during 1994-95. MATERIAL AND METHOD: Eighty two S. pyogenes strains isolated in 1986 and 67 strains isolated in 1994-95, were studied. MIC 50 and 90 were determined by and agar dilution method for penicillin, ampicillin, cefazolin, cefuroxime, erythromycin, roxithromycin and miocamycin. RESULTS: Eighty eight strains came from skin of soft tissues, 19 from surgical wounds, 18 from invasive infections, 15 from pharyngeal swabs and 9 from other locations. All strains were susceptible to penicillin, ampicillin, cefazolin, cefuroxime, roxithromycin and miocamycin. Ninety nine percent of strains were susceptible to erythromycin. Strains isolated in 1995-95 had a higher MIC 50 and 90 for erythromycin than those isolated in 1986. CONCLUSIONS: The changes in susceptibility to erythromycin of recently isolated strains could be due to the widespread use of macrolides in Chile.


Subject(s)
Ampicillin/pharmacology , Cephalosporins/pharmacology , Macrolides/pharmacology , Penicillins/pharmacology , Streptococcus pyogenes/drug effects , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Humans , Infant , Infant, Newborn , Microbial Sensitivity Tests , Middle Aged
5.
Rev Med Chil ; 122(5): 487-95, 1995 May.
Article in Spanish | MEDLINE | ID: mdl-7724887

ABSTRACT

A critical step in any epidemiologic research concerning nosocomial infections is the precise identification of the responsible pathogen. The present work utilized a molecular approach -plasmids identification, restriction length polymorphism DNA analysis, and random amplified polymorphic DNA- for the characterization of 6 nosocomial outbreaks due to 52 strains of methicillin-resistant Staphylococcus aureus (MRSA). In these episodes, the clinic-epidemiologic and phenotypic analysis (antibiotype) pointed to a nosocomial infection. Through molecular analysis it was possible to establish, in a very precise way, clonality due to MRSA strains in 2 of the studied outbreaks; the same type of analysis allowed to eliminate a MRSA clonal origin in the remainder 4 episodes. The antibiogram was not an useful analytic tool due to its poor discriminatory power. Also, through a PCR procedure, it was possible to identify the presence of the gen mecA in every of the 52 MRSA strains studied.


Subject(s)
Cross Infection/microbiology , Methicillin Resistance/genetics , Staphylococcal Infections/microbiology , Staphylococcus aureus/genetics , Base Sequence , Child , DNA Restriction Enzymes , Female , Humans , In Vitro Techniques , Male , Microbial Sensitivity Tests/methods , Molecular Sequence Data , Plasmids , Staphylococcus aureus/drug effects
6.
Rev Med Chil ; 121(12): 1359-66, 1993 Dec.
Article in Spanish | MEDLINE | ID: mdl-8085058

ABSTRACT

The infection caused by Mycobacterium tuberculosis is highly prevalent in our country and is considered an emergent pathology in developed countries. The amplification of specific gene segments with diagnostics purposes is an alternative to identify fastidious and slow growing infective agents, being Mycobacterium tuberculosis one of them. Two polymerase chain reactions (PCR) directed to the amplification of a 294bp gene segment encoding a portion of a 65KD heat shock protein and 317 bp gene segment of a repetitive DNA segment (IS 6110) of Mycobacterium tuberculosis, have a sensibility of 80 to 91.3% and a specificity of 83.9 to 100% when used in the identification of Mycobacterium tuberculosis in 2 group of clinical samples, both compared to Koch's culture and or Ziehl-Neelsen stain. The diagnostic procedure is particularly useful in diagnosis of tuberculosis of extrapulmonary origin.


Subject(s)
Genes, Bacterial/genetics , Mycobacterium tuberculosis/genetics , Tuberculosis/diagnosis , Base Sequence , Humans , Molecular Sequence Data , Nucleic Acid Amplification Techniques , Polymerase Chain Reaction , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL